Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Onyx Therapeutics, Inc.
Novartis
Information provided by (Responsible Party):
SCRI Development Innovations, LLC
ClinicalTrials.gov Identifier:
NCT01496118
First received: December 15, 2011
Last updated: June 10, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2016
  Estimated Primary Completion Date: February 2016 (Final data collection date for primary outcome measure)
No publications provided by SCRI Development Innovations, LLC

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):